Washington Hospital

Summary

Washington Hospital is a medical facility located in Fremont, California. This center is recognized for care of Breast Cancer, Breast cancer, Ductal Carcinoma In Situ, Lung Cancer, Cancer and other specialties. Washington Hospital is involved with conducting 33 clinical trials across 48 conditions. There are 2 research doctors associated with this hospital, such as Bogdan S. Eftimie and Jes Alexander.

Top PIs

Clinical Trials running at Washington Hospital

Breast Cancer

Lung Cancer

Prostate Cancer

Cancer

Breast cancer

Prostate Adenocarcinoma

Colon Cancer

Anorexia Nervosa

Blood Cancers

Anorexia

Low Dose Tamoxifen

for Breast Cancer

This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.

Recruiting

2 awards

Phase 3

8 criteria

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

Recruiting

2 awards

Phase 3

13 criteria

Cognitive Training

for Breast Cancer Survivors

This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.

Recruiting

1 award

N/A

5 criteria